Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,554.72
-1,729.62(-3.44%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Sinopharm Group Co. Ltd. (SHTDF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

2.8075

+0.2075

(+7.98%)

At close: 09:33AM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	8.28B
Enterprise value	9.66B
Trailing P/E	6.38
Forward P/E	8.19
PEG ratio (5-yr expected)	10.16
Price/sales (ttm)	0.10
Price/book (mrq)	0.77
Enterprise value/revenue	0.12
Enterprise value/EBITDA	2.60

Trading information

Stock price history

Beta (5Y monthly)	0.83
52-week change ³	-25.29%
S&P500 52-week change ³	26.43%
52-week high ³	3.4800
52-week low ³	2.3000
50-day moving average ³	2.6776
200-day moving average ³	2.6734

Share statistics

Avg vol (3-month) ³	508
Avg vol (10-day) ³	890
Shares outstanding ⁵	1.34B
Implied shares outstanding ⁶	3.19B
Float ⁸	1.34B
% held by insiders ¹	0.01%
% held by institutions ¹	62.15%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.12
Forward annual dividend yield ⁴	4.63%
Trailing annual dividend rate ³	0.87
Trailing annual dividend yield ³	33.46%
5-year average dividend yield ⁴	3.85
Payout ratio ⁴	28.75%
Dividend date ³	31 Aug 2017
Ex-dividend date ⁴	17 Jun 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	1.48%
Operating margin (ttm)	2.30%

Management effectiveness

Return on assets (ttm)	3.33%
Return on equity (ttm)	12.37%

Income statement

Revenue (ttm)	598.32B
Revenue per share (ttm)	191.73
Quarterly revenue growth (yoy)	1.20%
Gross profit (ttm)	N/A
EBITDA	23.79B
Net income avi to common (ttm)	8.88B
Diluted EPS (ttm)	0.4100
Quarterly earnings growth (yoy)	-10.70%

Balance sheet

Total cash (mrq)	48.91B
Total cash per share (mrq)	15.67
Total debt (mrq)	81.02B
Total debt/equity (mrq)	65.95%
Current ratio (mrq)	1.36
Book value per share (mrq)	24.40

Cash flow statement

Operating cash flow (ttm)	10.39B
Levered free cash flow (ttm)	-724.77M